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Recent investigations indicate an abnormal binding of 
gluten or gliadin to lymphocytes or intestinal mucosa 
cells in gluten sensitive enteropathy. Since dermatitis 
herpetiformis is closely associated to gluten sensitive 
enteropathy, similar receptors could also exist in the 
skin of patients with dermatitis herpetiformis. To prove 
this hypothesis, skin of normal volunteers and unin-
volved skin of 3 patients with dermatitis herpetiformis 
was investigated for the presence of gliadin and gliadin 
binding sites. In vivo bound gliadin was not found by 
direct immunofluorescence using 3 different rabbit an-
tigliadin antisera. 
In order to test skin for gliadin binding sites, normal 
sera and autologous dermatitis herpetiformis sera con-
taining 25 mg% gliadin and tritium labeled gliadin, re-
spectively, were used for incubation of normal and der-
matitis herpetiformis skin cryocut sections and of nor-
mal and dermatitis herpetiformis skin specimens, grown 
under organ culture conditions. As checked by direct 
immunofluorescence and autoradiography, there was no 
specific in vitro binding of gliadin, indicating that gliadin 
does not fix to normal human or dermatitis herpetiformis 
skin. Thus, the role of gliadin in the fixation in vivo, of 
antibodies or immune complexes to skin in dermatitis 
herpetiformis, remains obscure. 
The association of dermatitis herpetiformis (DH) with gluten 
sensitive enteropathy (GSE) is well established [1]. It has been 
postulated that immunogenetically determined surface antigens 
on gut epithelial cells or lymphocytes, represent binding sites 
for gluten or gliadin, the latter representing a subfraction of 
gluten protein. This binding could be due to an additional 
endogenous serum factor [2] and could initiate an immunolog-
ical response which leads to a production of gliadin antibodies, 
and subsequently, to cytotoxic mechanisms [3]. Similar recep-
tors for gluten protein could also be expressed on the surface of 
dermal cells [2]. Previous studies, based on standard elution 
procedures and direct immunofluorescence (IF) failed to detect 
gluten in the skin of patients with DH [2,4 and our own 
unpublished observations]. Expanding on these investigations 
the present study was undertaken in order to prove whether 
specific gliadin binding sites exist in uninvolved DH and normal 
skin. 
MATERIALS AND METHODS 
Three patients exhibiting the classical clinical, histological and IF-
fea tures of DH were investigated [2). Despite low suLfone trea tment 
(25- 50 mg of diaminodiphenyl sulfone per day) for at least 1 yr, the 
pa tients experienced minor relapses under therapy. 
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Biopsies were taken during the acute exacerbation of the disease; 
none of the pa tients exhibited clinical symptoms of GSE and none was 
on a gluten-free diet. Uninvolved buttock skin of the DH patients and 
of 3 healthy volunteers was obta ined by shave biopsy under local 
anesthesia, and used for the experiments. Serum samples were ta ken 
from the patients and the normal individuals-no longer than 24 hr 
prior to the experiments. 
Antisera 
Fluorescein labeled antisera: F luroescein labeled antisera (goat 
anti-human-Ig (polyvalent) , -IgG, -IgM, -IgA, -C", and goat anti rabbit 
Ig) (Hyland Laboratories, Costa Mesa, CAl were used in a dilu tion of 
1:16 (pBS pH 7,4 containing 4% BSA) . 
Antigliadin antisera: Two random bred rabbits weighing 2.0-2.6 kg 
were immunized by injecting, either 10 mg of gliadin (Serva Heidelberg, 
W. Germany) in PBS with Freud's complete adjuvant (1:1), intrader-
mally, or 20 mg of gliadin in PBS intraperitoneaLly, at inten rals of 2 
weeks. Tluee courses of immunization yielded antigliadin antibody 
titers of 1:32.000 and 1:512 respectively, as checked by passive hemag-
glutina tion. The ac tivity of the antibodies was determined by radioim-
munoassay [5). In addition, a commercially available rabbit anti gliadin 
serum (Behring Werke,Marburg/ Lahn, W. Germany) was employed . 
Ant igliadin antisera were used in a dilution of 1:5 (PBS - 4% BSA) . 
Detection of Circulating Antibodies 
Au.toantibodies: Sera of patients a nd of normal volun teers, diluted 
1:10 and 1:20 (PBS-4 %BSA) were tested by standard indirect IF [6] 
us ing polyvalent antihuman Ig conjugate and normal human skin, 
monkey esophagus, ra t liver, rat kidney and rat s tomach, as substra tes . 
Gliadin antibodies: Sera of patients and of normal volunteers were 
diluted 1:10 (PBS - 4% BSA) , and tes ted by radioimmunoassay [7], and 
defined antigen substrate spheres (DASS) system [8], for the presence 
of circulating gliad in antibodies. 
Detection of in. Vivo Fixed Gliadin and Immunoglobulin 
Skin specimens obta ined from DH patients and normal volunteers 
were snap frozen in liquid nitrogen, stored at -70°C for up to 48 hr, 
and then processed for routine immunofluorescence [6). Antihuman Ig 
(polyva lent) , IgG . IgM, IgA and Ca conjugates and the rabbit antigliadin 
an tisera were used. To demonstra te binding of antigliadin sera a flu-
oresceinated anti rabbit Ig conjugate was employed in a second step. 
Detection of Gliadin. Binding Sites 
Immunofluorescence: DH skin cryostat sections (6 /lm) were incu-
bated for 1 hI' at 37°C in autologous serum, containing 25 mg% gliadin 
(ICN Pharmaceuticals Inc.) ; and in normal serum and normal serum 
containing 25 mg% gLiadin. 
According to Langner and Christophers [9] gliadin was solubilized in 
serum by mechanical stirring for 14 hI' a t room tempera ture at a 
concentration of 25 mg%. Cryostat sections of normal skin were incu-
bated in an identical set up in autologous and DH serum with and 
without gliadin. 
After incubation the sections were washed carefully with PBS and 
then incubated with rabbit antigliadin serum followed by the appropri-
a te conjugate. 
Organ culture experiments: Organ culture of skin was carried out 
according to the method previously described [10). Skin slices 0.5 mm 
th ick obtained from DH patients and normal volunteers were washed 
in medium 199 (Flow Laboratories), cut to approximately 4 X 4 mm 
pieces, placed on lens paper and immersed in the culture medium. 
Culture media consisted of autologous undiluted DH sera or normal 
sera with and wi thout 25 mg% gliadin. Specimens were grown for 6 and 
for 30 hr, carefu lly washed in PBS, quick frozen in liquid nitrogen and 
s tored at -70°C for not longer than 48 hr. Tissue was cut into 6 /lm 
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sections and processed for IF using rabbit anti gliadin serum (Behring) 
followed by fluorescein conjugated goat anti rabbit Ig serum. 
Autoradiography 
3H labeling of g lia.din: Gliadin was labeled using a modification of 
the method described by Gisslow and McBride [ll] for "H labeling of 
collagen. Gliadin (100 mg) (Serva Heidelberg, W.· Germany) was dis-
solved in a mixture of 50 ml of a 0.2 m Na2CO"/NaHCO,, buffer (pH = 
10,0) - and absolu te etha nol (1:2). Gliadin was allowed to react with "H-
acetic anhydride (Hadiochemical Center, Amersham, England) byadd-
ing 50 mCi of the reagent (specific activity: 52 mCi/mg) in 0,5 ml 
benzene to 10 ml of the gliadin solution. After 150 min of vigrous 
stirring ' at lOoC the chemical reaction was stopped by acidification to 
pH 5,0. The sample was dialyzed at 4°C for 24 hr against PBS. The 
specific activity of the labeled gliadin was found to be 100 x lOG 
disintegrations per minute (dpm)/mg = 45/LCi/mg. 
Autoradiographic Experiments: Specimens of DH and normal skin, 
processed for organ culture, were cultured for 30 hr in media consisting 
of DH and normal sera, respectively, which were diluted 1:1 with a 
solu tion conta ining 50 mg% "H-gliadin. Thereafter the specimens were 
washed carefully 3 times in medium 199, fixed in buffered neutral 
formalin (pH = 7,2) and processed for autoradiography [12]. For control 
purposes additional specimens of DH and normal skin were incubated 
prior to the exposure to labeled gliadin, in DH serum or normal serum 
containing 25 mg% of unlabeled gliadin. The control specimens were 
subsequently washed in medium 199 and incubated for another 20 hr 
in media containing "H-gliadin as described above. 
RESULTS 
In the skin of our 3 DH patients, exclusively IgA was found 
in the tips of the dermal papillae whereas such deposits were 
absent in the normal controls. No autoantibodies (ANA, anti-
basement membrane zone antibodies, antireticulin antibodies 
etc.) were found in DH and normal sera. There were no circu-
lating antigliadin antibodies detectable by radioimmunoassay 
and by the DASS-system. Neither DH nor normal skin ex-
hibited specific fluorescence when tested with 3 different rabbit 
antigliadin sera. 
Immunofluorescence failed to demonstrate in vitro binding 
of gliadin to DH or normal skin on cryostat sections after short-
term incubation, and in organ culture after gliadin incubation 
for up to 30 hr. In addition, there was no specific binding of 
tritium labeled gliadin to DH and normal skin under organ 
culture condition. 
DISCUSSION 
The association of DH and GSE is well established as dem-
onstrated by similar intestinal changes [1,2], identical immu-
nogenetical markers (HLA-B8, HLA-DW3, GSE/DH B-cell 
antigen) [13,14], the presence of circulating gliadin antibodies 
in both diseases [7] and the therapeutic response to gluten-free 
diet [15,16]. This association and the fact that gluten proteins 
are responsible for the development of GSE, prompted specu-
lations that gluten proteins, such as gliadin, could be involved 
also in the development of the skin lesions in DH [2,17,18]. 
Expanding on previous attempts, to investigate gliadin in DH 
skin [2,4] we employed several different and mOre sensitive 
methods for the demonstration of gliadin or gliadin binding 
sites in DH and normal skin. 
The failure of ourselves (and of others) [2,4] to detect gliadin 
and gliadin bindings sites in DH skin specimens may be due to 
the fact that either gliadin or gliadin binding sites are absent in 
DH skin unless all the methods employed are not specific or 
not sensitive enough. 
Another explanation for the negative results of our experi-
ments would be that only structurally altered gliadin is involved 
or structurally (antigenically?) normal gliadin is covered by 
immunoglobulins (e.g. IgA) and thus its antigenic determinants 
may remain undetected by the antigliadin antisera used. 
Gliadin bindings sites could also be blocked already by gliadin 
or may react only with structurally altered gliadin proteins. 
Proof Or disproof of such hypotheses needs further investiga-
tions. Present knowledge, however, indicates that gliadin does 
not represent an antigenic site responsible for immunoglobulin 
desposits in DH skin. 
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